FDA Warns of Shortage of Critical Antibiotic
(IntegrityPress.org) – Amoxicillin is a penicillin-based antibiotic that’s among the most commonly prescribed drugs of its type in the United States. Doctors typically approve it for use by patients with dental abscesses, chest infections (including pneumonia), stomach ulcers, and ear infections in children. Pharmacies distribute the medication in both liquid and capsule forms. The Food and Drug Administration (FDA) has just issued a warning about a shortage in the supply of amoxicillin across the United States.
The shortage came to light when retail pharmacies across the country began complaining they couldn’t access liquid amoxicillin products in sufficient quantities. It’s reportedly unclear how long issues with the supply of the drug will persist.
The FDA notice mentions five drug manufacturers responsible for producing amoxicillin products; Teva Pharmaceuticals, Rising Pharma Holding Inc., Sandoz, Hikma Pharmaceuticals, and Aurobindo USA. Four of the companies cited increased demand as the reason behind their inability to provide sufficient quantities of the products, while Sandoz lists the reason for shortages simply as “other.”
One of the most commonly used antibiotics in the country, amoxicillin, is in short supply, federal health officials say. https://t.co/w79hp6QJBZ
— NBC News (@NBCNews) November 3, 2022
An FDA representative told NBC News several factors might cause supply issues around certain medicines, including problems with drug quality, distribution issues, discontinuations, and delays.
Reports state doctors may prescribe other antibiotics in place of amoxicillin.
Copyright 2022, IntegrityPress.org